Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy

Ommoleila MolaviBiotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; ;Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran; ;Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, CanadaCorrespondence[email protected]

Farzaneh NarimaniFaculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran;

Farshid AsiaeeFaculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran;

Simin SharifiFaculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran;

Vahideh TarhrizFaculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran;

Ali ShayanfarFaculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran;

Mohammadsaied HejaziFaculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran;

Raymond LaiDepartment of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada

show all

Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy

Ommoleila_Molavi_et_al_supplemental_content.zip

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy

Ommoleila_Molavi_et_al_supplemental_content.zip

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date